FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Bagsværd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market with a full portfolio of glucagon-like peptide 1 (GLP-1) receptor agonists, modern ...

GLP-1 modulators, formally known as glucagon-like peptide-1 receptor agonists, function by enhancing insulin secretion, ...